Abstract
Myeloproliferative syndromes (MPS) are characterized by clonal proliferation patterns of hematological precursor cells with a tendency to develop acute leukemia. Cytopenias typically seen in myelodysplastic syndrome (MDS) are uncommon, as are dysplastic morphological features. Hence a pathogenesis different from MDS is suspected, which is an important reason to separate the discussion and classification of MPS from MDS
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Niemeyer CM, Arico M, Basso G et al (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89:3534–3543
Germing U et al (2008) Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 87:691–699
Vardiman JW (2010) The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact 184:16–20
Yin CC et al (2010) Recent advances in the diagnosis and classification of myeloid neoplasms – comments on the 2008 WHO classification. Int J Lab Hematol 32:461–476
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kühne, T. (2011). Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms. In: Imbach, P., Kühne, T., Arceci, R. (eds) Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20359-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-20359-6_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20358-9
Online ISBN: 978-3-642-20359-6
eBook Packages: MedicineMedicine (R0)